- Home
- ARAY vs GEVO Comparison
ARAY vs GEVO Comparison
Compare ARAY & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- GEVO
- Stock Information
- Founded
- ARAY 1990
- GEVO 2005
- Country
- ARAY United States
- GEVO United States
- Employees
- ARAY N/A
- GEVO N/A
- Industry
- ARAY Medical/Dental Instruments
- GEVO Major Chemicals
- Sector
- ARAY Health Care
- GEVO Industrials
- Exchange
- ARAY Nasdaq
- GEVO Nasdaq
- Market Cap
- ARAY 229.3M
- GEVO 246.8M
- IPO Year
- ARAY 2007
- GEVO 2011
- Fundamental
- Price
- ARAY $1.34
- GEVO $1.26
- Analyst Decision
- ARAY
- GEVO Buy
- Analyst Count
- ARAY 0
- GEVO 2
- Target Price
- ARAY N/A
- GEVO $7.58
- AVG Volume (30 Days)
- ARAY 1.1M
- GEVO 3.9M
- Earning Date
- ARAY 08-13-2025
- GEVO 08-07-2025
- Dividend Yield
- ARAY N/A
- GEVO N/A
- EPS Growth
- ARAY N/A
- GEVO N/A
- EPS
- ARAY 0.01
- GEVO N/A
- Revenue
- ARAY $465,251,000.00
- GEVO $42,034,000.00
- Revenue This Year
- ARAY $3.87
- GEVO $1,022.79
- Revenue Next Year
- ARAY $0.09
- GEVO $12.26
- P/E Ratio
- ARAY $201.83
- GEVO N/A
- Revenue Growth
- ARAY 8.06
- GEVO 145.38
- 52 Week Low
- ARAY $1.14
- GEVO $0.48
- 52 Week High
- ARAY $2.95
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- ARAY 45.59
- GEVO 52.12
- Support Level
- ARAY $1.21
- GEVO $1.17
- Resistance Level
- ARAY $1.29
- GEVO $1.41
- Average True Range (ATR)
- ARAY 0.06
- GEVO 0.08
- MACD
- ARAY 0.00
- GEVO 0.00
- Stochastic Oscillator
- ARAY 43.48
- GEVO 51.61
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.